Brind.

Kori Wallace was appointed vice president at AbbVie.

2 reports, 2 independent Updated 00:00

Still developing

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Kori Wallace was appointed vice president at AbbVie.

Who's involved

What this event is mainly about

Kori Wallace AbbVie

How it developed

Newest first. Tap a step to see who reported it.

00:00Wallace is presenting AbbVie results at a Congress in Barcelona.1 source
- prnewswire.com
Aug 21Kori Wallace joins AbbVie as vice president.1 source
- PR Newswire

Keep exploring

The entities involved

Kori Wallace
researcher

Nothing else this week.
AbbVie
pharmaceutical company
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.08:04
- Ken Griffin made investment moves on October 18, 2026, buying shares of AbbVie and Abbott Laboratories, and boosting Eli Lilly shares.Sun 12:36

Coverage

Newest first; wire copies grouped

00:00prnewswire.com
Aug 21PR NewswireAbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata In the second replicate study (Study 1) of the pivotal Phase 3 UP-AA cl